Syngene International EBITDA per Share

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.